In the ongoing battle against drug-resistant bacteria, a groundbreaking innovation has emerged: a new class of antibiotics developed by Kinvard Bio.This promising advancement arrives at a crucial time, as antibiotic resistance continues to escalate, with the World Health Organization reporting millions of deaths linked to this global crisis.